Clustering data with hclust algorithm for (Study ST001299)
Reversed phase POSITIVE ION MODE (Analysis AN002163)| Metabolite | Structure | F1 | F2 | F3 |
|---|---|---|---|---|
| 2,3-Dihydroxybenzoic acid | ME304025 | 1.05 | 0.92 | 1.04 |
| 4-Phosphopantothenate | ME303935 | 1.55 | 0.60 | 0.82 |
| 2-Aminooctanoic acid | ME303956 | 0.64 | 0.75 | 1.61 |
| 3-Phospho-serine | ME303929 | 1.26 | 0.91 | 0.80 |
| 4-Hydroxyphenyllactate | ME303900 | 1.30 | 0.85 | 0.85 |
| 3-Hydroxybutyric acid | ME303924 | 0.91 | 1.05 | 1.04 |
| 3-S-Methylthiopropionate | ME303963 | 2.15 | 0.52 | 0.11 |
| 3-Methylphenylacetic acid | ME303955 | 0.77 | 0.85 | 1.38 |
| 4-Aminobutyrate | ME304004 | 0.98 | 1.12 | 0.90 |
| 2-Isopropylmalic acid | ME303913 | 1.41 | 0.89 | 0.69 |
| 2-Keto-D-gluconate | ME303918 | 1.54 | 0.76 | 0.70 |
| 2-Keto-isovalerate | ME303969 | 1.46 | 0.92 | 0.61 |
| 3-Phosphoglycerate | ME303919 | 1.69 | 0.69 | 0.62 |
Factors:
| F1 | Treatment:Control |
| F2 | Treatment:High Dose TCDF |
| F3 | Treatment:Low Dose TCDF |